Pharaceutical attention to the hypertensive patient
DOI:
https://doi.org/10.33448/rsd-v10i15.22466Keywords:
Pharmacist; Arterial hypertension; Medicines.Abstract
Hypertension is a clinical condition with characteristics related to the sustained elevation of blood pressure levels greater than or equal to 140/90 mmHg. It is a disease that stands out in the current national epidemiological scenario because of its high incidence and prevalence. The objectives of this study are to expand, through a literature review, the knowledge about pharmaceutical assistance to patients diagnosed with arterial hypertension, to analyze the factors related to the use of antihypertensive drugs, and to demonstrate the importance of the pharmaceutical professional in the control of arterial hypertension, as well as in the adequate use of the drugs prescribed to the patient. In Brazil, this disease contributes directly or indirectly to deaths from cardiovascular disease and affects the population of adult individuals, the elderly being the great majority of this group. The diagnosis of hypertension is basically established by the finding of permanently elevated blood pressure levels above normal limits, when blood pressure is determined through appropriate methods and conditions. Currently, faced with the pandemic of COVID-19 one of the most frequent comorbidities in patients who died was arterial hypertension. The pharmaceutical activity is primordial in the attention to the hypertensive patient and is recognized as a professional activity able to capture, conduct, improve, access and promote all the benefits of pharmacotherapy.
References
ANDRADE, K. Prevalência de interações medicamentosas potenciais em indivíduos hipertensos acompanhados na estratégia de saúde da família. J.Health Biol Sci. v. 6, n.4. p. 405-411. Agosto, 2018.
BARROSO, W.K.S. et al. Diretrizes Brasileiras de Hipertensão Arterial. Departamento de Hipertensão Arterial da Sociedade Brasileira de Cardiologia (DHA-SBC), Sociedade Brasileira de Hipertensão (SBH), Sociedade Brasileira de Nefrologia (SBN). 2020. Disponível em: http://departamentos.cardiol.br/sbc-dha/profissional/pdf/Diretriz-HAS-2020.pdf. Acesso em 5 de set. 2021.
BRASIL. Ministério da Saúde. Vigitel Brasil, 2016: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. Brasília;2016.
BRAZ, A. L.; FERREIRA, E. C.; GUEDES, D. N.; COSTA, K. V. M. C.; COREIA, N. A.; ALBUQUERQUE, K. L. G. Atenção Farmacêutica em pacientes hipertensos do Hospital Universitário Lauro Wanderley. Revista de Ciências Médicas e Biológicas, João Pessoa, v. 16, n. 1, p. 45-51. 2017.
CAMARGO PNN, Tenani CF, Bulgareli JV, Guerra LM, Silva RP, Batista MJ. Estudo qualitativo da percepção de usuários hipertensos e diabéticos sobre saúde na Atenção Primária. Rev Ciênc Med. 2021.
CAREY, R. M. Prevention and Control of Hypertension. JACC Health Promotion Series. J Am Coll Cardiol. 2018.
COSTA JMBS, Barreto MNSC, Gomes MF, Fontbonne A, Cesse EÂP. Avaliação da estrutura das farmácias das Unidades de Saúde da Família para o atendimento aos portadores de hipertensão arterial sistêmica e diabetes mellitus em Pernambuco. Cad Saúde Colet, 2020.
COSTA KS, Tavares NU, Mengue SS, Pereira MA, Malta DC, Silva JB Jr. Obtenção de medicamentos para hipertensão e diabetes no Programa Farmácia Popular do Brasil: resultados da Pesquisa Nacional de Saúde, 2013. Epidemiol Serv Saude. 2016.
FEITOSA, A.D.M. Relationship between office isolated systolic or diastolic hypertension and white-coat hypertension across the age spectrum: a home blood pressure study. J Hypertens. 2020,
FERNANDES PSLP, Bezerra IMP, Temer JCC, Abreu LC. Acesso e uso racional de medicamentos para hipertensão na atenção primária à saúde. Rev Bras Promoç Saúde. 2020.
GOTTLIEB DJ, Punjabi NM. Diagnosis and Management of Obstructive Sleep Apnea: A Review. JAMA. 2020.
LIMA TAM, Fazan ER, Pereira LLV, et al. Acompanhamento farmacoterapêutico em idosos. Arq. Ciênc. Saúde 2016;
MALACHIAS, M.V.B. 7ª Diretriz Brasileira de Hipertensão Arterial, v. 107, n. 3, Suplemento. 2016.
MARTINEZ-GARCIA, M. A. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013.
MENDES, Driely Dandary Soares. LOPES, Yanna Gabriele Guimarães. DUARTE, Gabriella Mendes. Interações medicamentosas mais comuns com os anti-hipertensivos: Uma revisão de literatura. Revista Científica Multidisciplinar Núcleo do Conhecimento. Ano 05, Ed. 11, Vol. 17, pp. 103-113. Novembro de 2020.
MENGUE, S. S. Acesso e uso de medicamentos para hipertensão arterial no Brasil. Rev Saúde Pública, v.22, n. 8. 2016.
MENNI. C, et al. Heritability analyses show visit-to-visit blood pressure variability reflects different pathological phenotypes in younger and older adults: evidence from UK twins. J Hypertens. 2013.
MENTE A, O’Donnell et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018.
MILLS, K.T, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 populationbased measurement studies with 19·1 million participants. Lancet. 2017.
MORAIS, C.A.C.; Fatores relacionados à adesão ao tratamento anti-hipertensivo: fundamentação a partir da teoria de Imogene King. Revista Nursing. 2021.
PICON, RV, Fuchs FD, Moreira LB, Fuchs SC. Prevalence of hypertension among elderly persons in urban Brazil: a systematic review with meta-analysis. Am J Hypertens. 2015.
PIEPOLI, M. F, The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Eur Heart J. 2016.
PRÉCOMA, D. B, et al. Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia. Arq. Bras. Cardiol. 2019.
ROCHA AS, Pinho BATD, Lima EN. Hipertensão arterial entre idosos: comparação entre indicadores do Ceará, do Nordeste e do Brasil. Rev Bras Promoç Saúde. 2021.
ROERECKE, M. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017.
SOUZA, A.C, Borges JW, Moreira TM. Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis. Rev Saude Publica. 2016.
STRABELLI, Tânia Mara. COVID-19 e o Coração. Arq. Bras. Cardiol. Abr 2020. Disponível em: https://www.scielo.br/j/abc/a/NWKkJDxLthWSb53XFV9Nhvn/?lang=pt. Acesso em 20 out. 2021.
TORRES, Geanne Maria Costa et al. Comunicação terapêutica na interação profissional de saúde e hipertenso na estratégia saúde da família. Rev. Gaúcha Enferm. 2017.
YUGAR-TOLEDO, J. C. Brazilian Position Statement on Resistant Hypertension. Arq Bras Cardiol. 2020.
ZHONGHUA, Liu Xing Bing XueZaZhi. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Tayse Adália Gomes Nunes; Rafaela Rocha Pinto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
